Cite
APA Citation
Grimmer, T., Rabe, C., Navarro, M., Clayton, D., Manuilova, E., Peters, O., Eichenlaub, U., Smith, J., Ostrowitzki, S., Honigberg, L., & Bittner, T. (n.d.). p06 Concordance of florbetapir (18F) PET and Elecsys® β-Amyloid(1–42) CSF immunoassay in the CREAD (BN29552) study of crenezumab in prodromal-to-mild AD. Clinical neurophysiology, 130(8), e148–e149. http://access.bl.uk/ark:/81055/vdc_100086839099.0x00000e